Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 242 participants.
Also called NCT02325973
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 242 participants
- Sponsor
- Registry
-
NCT02325973
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT02325973. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-02 (actual). Results posted on 2025-08-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI
- Acronym
- AMICRO
- Condition
- Multi Vessel Coronary Artery Disease
- Condition
- STEMI
- Intervention (Device)
- PressureWire Certus guidewire
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02325973- Content hash
d906325cc8fd2ffe112d5fea0c8dd68c17e648d89293d02bd0c459939bd38676